INVICTUS AND GTEC HOLDINGS ANNOUNCE FORMAL TERMINATION OF MERGER
PLANS AND MAINTAIN EXISTING WORKING RELATIONSHIP
Vancouver,
BC, Canada -- January
15,
2019 -- InvestorsHub NewsWire -- INVICTUS MD
STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA:
8IS1) announced that pursuant to the terms of a
non-binding letter of intent (the "LOI") entered into with
GTEC Holdings Ltd.
(TSXV: GTEC; OTC:GGTTF)
("GTEC"), as
announced on November 16, 2018, the parties have mutually agreed to
terminate the LOI and not proceed with the
merger, with
a preference for increased strategic collaboration in building out
the route to adult consumer retail side.
GTEC and Invictus
maintain a strong working relationship based on its previously
announced definitive agreement dated August 30, 2018
whereby:
1)
GTEC has entered
into a $2m convertible loan facility with Invictus, at an interest
rate of prime plus 5%. The loan facility is convertible at $1.50
per common share of GTEC and is due on the date that is two years
following the date of the first draw. As of the date hereof, GTEC
has drawn-down the facility.
2)
As additional
consideration, GTEC has provided Invictus with a right of first
refusal to fill up to 30% of any cannabis purchase order
domestically and internationally (whether for flower or oil) that
GTEC, or its wholly-owned subsidiaries are seeking to purchase from
third party Licensed Producers for a period of two
years.
"Invictus is
continually aiming to realize its vision of building a
global
cannabis company
anchored on its Western Canadian roots, with a focus on satisfying
patients' and consumer's needs in the medical and recreational
markets, respectively" said George E.
Kveton, President and
CEO of
Invictus. "We look
forward to maintaining and further increasing our strong, strategic
partnerships with companies like GTEC to support our five pillars
of distribution including medical, recreational, international,
Licensed Producer to Licensed Producer, and retail."
"We look forward to
continuing down the path of GTEC becoming one of Canada's leading
premium focused and vertically integrated cannabis companies, while
maintaining a strong working relationship with the Invictus team"
said Norton Singhavon, Founder, Chairman & CEO.
"2019 will prove to be an instrumental year for GTEC
as
we continue to
execute on our vision and strategy within the premium cannabis
market in Canada."
For more
information, please visit
www.invictus-md.com.
On Behalf of the
Board,
George E.
Kveton
Chief
Executive Officer and Director
Jessica
Martin
Vice
President, Public Relations and Regulatory
Affairs
(833)
879-4363
About
Invictus
Invictus is a
global cannabis company offering a selection of products under a
wide range of brands. Our integrated sales approach is defined by
five pillars of distribution including medical, adult-use,
international, Licensed Producer to Licensed Producer and retail
stores.
Invictus has
partnered with business leaders to convey our corporate vision,
including KISS music legend and business mogul Gene Simmons
as our Chief Evangelist Officer. To meet growing demand, Invictus
is expanding its cultivation footprint, with three cannabis production facilities
licensed under the Cannabis Act and
Cannabis Regulations in Canada. To accommodate international
sales, Invictus' wholly-owned subsidiary, Acreage Pharms Ltd.
("Acreage Pharms"), has designed and is currently building its
Phase 3 purpose-built cultivation facility to be European Union
Good Manufacturing Practices ("EU-GMP") compliant. The
Company is
targeting up to 50 percent of production to medical
cannabis. To ensure consistency in quality and supply, Invictus
maintains all aspects of the growing process through its
subsidiary, Future Harvest Development Ltd. ("Future
Harvest"), a
high-quality fertilizer and
nutrients
manufacturer. Invictus drives sustainable long-term shareholder
value through a diversified product portfolio with over
70
Health Canada
approved strains and a multifaceted distribution strategy including
medical, adult-use, international, Licensed Producer to Licensed
Producer and retail stores. For more information visit
www.invictus-md.com.
Neither the
Canadian Securities Exchange nor its Regulation Services Provider
accepts responsibility for the adequacy or accuracy of this
release.